Conclusions : The TEG ® 6s system can improve diagnostic accuracy with a high degree of correlation to the Clauss assay. By using complementary data from CFF.MA (particularly above the RR for the other assays) and CK.MA a more complete assessment of hemostasis can be obtained.
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Conclusions : The TEG ® 6s system can improve diagnostic accuracy with a high degree of correlation to the Clauss assay. By using complementary data from CFF.MA (particularly above the RR for the other assays) and CK.MA a more complete assessment of hemostasis can be obtained. A. Woolley ; M. Bryant ; L. Marley ; S. Kitchen Sheffield Haemophilia and Thrombosis Centre, Coagulation Department, Sheffield, United Kingdom Background : The QXpert ( Grifols) is a recently launched fully automated, random access, cap piercing analyser using clotting, chromogenic and immunoturbidometric methods suitable for high volume laboratories. Liquid PT/INR (recombinant human tissue factor), APTT (ellagic acid/synthetic phospholipids) and fibrinogen (human thrombin) reagents are available for ease of use.
PB0151 | The New QXpert Analyser Is Suitable for Routine Use in High Volume Haemostasis Laboratories
Aims : We have evaluated the QXpert for routine use in comparison to a widely used alternative system as recommended by CLSI. Background : Thrombin generation assay (TGA) is known to be highly sensitive to direct oral anticoagulants (DOACs). It provides more information thank to its capacity to explore in more details the kinetic formation of thrombin. Devices with adsorbent properties that are used to remove DOACs from plasma samples are usually known to interfere with TGA parameters at normal tissue factor (TF) concentration (i.e. 5 pM of TF) by increasing the peak, the mVRI and by reducing the time-to-peak. This prevents the use a ratio of the conditions before/after removal of DOAC to assess the intensity of anticoagulation at the individual patients' level.
Methods

Aims : To assess the efficacy and the impact of the DOAC & Platelets
Filter (DP-Filter) device from the University of Namur on TGA parameters from plasma spiked with DOACs.
Methods : Normal pooled plasma (NPP) was mixed with apixaban, betrixaban, dabigatran, edoxaban or rivaroxaban at concentrations of 0-100-300-1000 ng/ml. Plasma were tested before and after filtration on the calibrated automated thrombogram using the PPPhigh reagent (20 pM of TF).
Results : All DOACs affect TGA parameters. Filtration with DP-Filter efficiently restores baseline value of the lag time at 105±9% and the ETP at 93±9% for all DOACs whatever the concentration. The peak parameters are restored with DP-Filter at 98±7% for edoxaban, rivaroxaban and betrixaban. However, it seems that the device is not able to totally restore initial peak in plasma samples spiked with apixaban and dabigatran (75±20% and 83±7%, respectively).
Conclusions : DP-filter device is effective in removing DOACs from plasma. It allows to recover the baseline TGA profile of the NPP. The use a ratio of the conditions before/after removal of DOAC appears to be feasible using reagents with high TF content. It could provide interesting information on the level of anticoagulation at the individual patient ' s level. Aims : As D-dimer assays are not standardized, the aim of the present study was to evaluate the inter-reagent agreement of results in the low range of concentrations.
PB0153 | Thromboelastography Cartridgebased System Measurements Reflect Both Platelet Count and Function Contribution to Clot Formation: An Ex-vivo Evaluation
Methods : For that purpose, we investigated plasma samples from 50 patients (31 males and 30 females, mean age=34 years, range:18-72) in whom D-dimer testing was prescribed for VTE exclusion. D-dimer was evaluated using 4 different quantitative automated latex agglutination-based assays: HemosIL D-dimer HS500 (Werfen),HemosIL Accustar D-dimer (Werfen),Innovance D-dimer (Siemens),STA-Liatest D-dimer (Stago), and with the Vidas D-dimer Exclusion II (BioMérieux).
Results : Test results (Table) were well correlated with those obtained with the Vidas (r 2 >0.40, except for one reagent).
The concordance of test results below or above the cut-off level of 250 ng/mL (270 for Liatest, as its limit of quantitation) assessed 
